Nasdaq: UTHR

United Therapeutics Corp. (UTHR)

United Therapeutics Corp. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker UTHR. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
UTHR
Exchange
Nasdaq
SEC CIK
1082554
Official filings
SEC EDGAR

Research UTHR

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is United Therapeutics Corp.'s stock ticker?

United Therapeutics Corp. trades under the ticker symbol UTHR on Nasdaq. Its SEC Central Index Key (CIK) is 1082554.

Where can I read United Therapeutics Corp.'s SEC filings?

The UTHR SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports United Therapeutics Corp. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze UTHR's financial statements?

The UTHR Financials page shows United Therapeutics Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does UTHR compare with its peers and the market?

The UTHR Peer Comparison page lines United Therapeutics Corp. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.